Top Markets
Coin of the day
CTI BioPharma Corp. CTI BioPharma Corp.

CTI BioPharma Corp.

CTIC
Ранг среди акций #12604
CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery,... CTI BioPharma Corp. is a biopharmaceutical company dedicated to the discovery, advancement, and commercialization of innovative, targeted treatments for blood cancers within the United States. Its key product is VONJO (pacritinib), an oral kinase inhibitor currently under investigation, specifically designed to target JAK2, FLT3, IRAK1, and CSF1R for the management of adult patients with myelofibrosis. The company holds licensing and collaboration agreements with Teva Pharmaceutical Industries Ltd., SBIO Pte Ltd., and Baxalta. Established in 1991 and based in Seattle, Washington, CTI BioPharma Corp. was previously known as Cell Therapeutics, Inc., adopting its current name in May 2014.
Цена акции
$9.09
Последняя синхронизация: 2023-06-23
Рыночная капитализация
$567.77M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля CTI BioPharma Corp. (CTIC)

Категория

История цены акций CTI BioPharma Corp. (CTIC)
Наивысшая цена закрытия: $9.07 2023-06-01

Наименьшая цена закрытия: $121.75K 1997-03-01
История цены акций CTI BioPharma Corp. с 1997 по 2026
Годовая динамика цены акций
Год Результативность
2023 59.07%
2022 173.23%
2021 -38.21%
2020 161.00%
2019 5.88%
2018 -53.69%
2017 -42.12%
2016 -61.16%
2015 -49.72%
2014 27.27%
2013 38.57%
2012 -76.52%
2011 -49.34%
2010 -67.69%
2009 680.34%
2008 -99.33%
2007 -70.14%
2006 -20.03%
2005 -71.45%
2004 -4.83%
2003 6.48%
2002 -68.99%
2001 -35.93%
2000 997.50%
1999 22.69%
1998 -81.36%
1997 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$755.62 6.68%
CH